RSV OA=ADJ-023, NCT05921903: A Study on the Immune Response and Safety of an RSV Vaccine When Given to Adults 18 Years of Age and Above Who Received Lung or Kidney Transplant and Are at an Increased Risk of Respiratory Syncytial Virus Lower Respiratory Tract Disease and Compared to Healthy Adults 50 Years of Age and Above |
|
|
| Active, not recruiting | 2 | 387 | Europe, Canada, Japan, US, RoW | RSVPreF3 OA Investigational Vaccine | GlaxoSmithKline | Respiratory Syncytial Virus Infections | 07/24 | 06/25 | | |
NCT05917522: Assessment of Biomarker-Guided CNI Substitution In Kidney Transplantation |
|
|
| Recruiting | 2 | 800 | US | Abatacept, Orencia, Standard of Care at US Transplant Centers | National Institute of Allergy and Infectious Diseases (NIAID) | Kidney Transplant | 07/27 | 07/29 | | |
| Active, not recruiting | N/A | 5000 | US | Prospera | Natera, Inc., University of Maryland | Kidney Transplant Rejection | 10/26 | 10/27 | | |
NCT06056102: CAR-T Cell Therapy for Desensitization in Kidney Transplantation |
|
|
| Recruiting | 1 | 20 | US | Cyclophosphamide, Cytoxan, CART-BCMA, Chimeric Antigen Receptor T cell (CART)/B cell maturation antigen (BCMA), huCART19, Chimeric Antigen Receptor T cell (CART)/ CD-19 Targeted Humanized CAR T Cell, Fludarabine, Fludara | National Institute of Allergy and Infectious Diseases (NIAID), University of Pennsylvania Clinical Cell and Vaccine Production Facility (CVPF) | Kidney Transplant, Kidney Failure, End Stage Renal Failure on Dialysis | 12/28 | 12/42 | | |
